{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:27:44Z","timestamp":1791908864384,"version":"4.3.4"},"reference-count":22,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","award":["MGU0372"],"award-info":[{"award-number":["MGU0372"]}],"id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,11,10]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the feasibility of a definitive trial of metformin to prevent type 2 diabetes in the postnatal period in women with gestational diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A multicentre, placebo-controlled, double-blind randomised feasibility trial with qualitative evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Three inner-city UK National Health Service hospitals in London.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Pregnant women with gestational diabetes treated with medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>2\u2009g of metformin (intervention) or placebo (control) from delivery until 1\u2009year postnatally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary outcome measures<\/jats:title>\n                    <jats:p>Rates of recruitment, randomisation, follow-up, attrition and adherence to the intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Secondary outcome measures<\/jats:title>\n                    <jats:p>Preliminary estimates of glycaemic effects, qualitative exploration, acceptability of the intervention and costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 302 eligible women, 57.9% (175\/302) were recruited. We randomised 82.3% (144\/175) of those recruited, with 71 women in the metformin group and 73 women in the placebo group. Of the participants remaining in the study and providing any adherence information, 54.1% (59\/109) took at least 75% of the target intervention dose; the overall mean adherence was 64% (SD 33.6). Study procedures were found to be acceptable to women and healthcare professionals. An increased perceived risk of developing type 2 diabetes, or a positive experience of taking metformin during pregnancy, encouraged participation and adherence to the intervention. Barriers to adherence included disruption to the medication schedule caused by the washout periods ahead of each study visit or having insufficient daily reminders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>It is feasible to run a full-scale definitive trial on the effectiveness of metformin to prevent type 2 diabetes in women with gestational diabetes, during the early postnatal period. Adherence and engagement with the study could be improved with more regular reminders and potentially the addition of ongoing educational or peer support to reinforce messages around type 2 diabetes prevention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN20930880\">ISRCTN20930880<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-073813","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T10:50:52Z","timestamp":1701168652000},"page":"e073813","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Metformin in the prevention of type 2 diabetes after gestational diabetes in postnatal women (OMAhA): a UK multicentre randomised, placebo-controlled, double-blind feasibility trial with nested qualitative study"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"isrctn20930880","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-2805","authenticated-orcid":false,"given":"Angeliki","family":"Bolou","sequence":"first","affiliation":[{"name":"Institute of Lifecourse Development: Centre of Chronic Illness and Aging, Faculty of Education, Health & Human Sciences, University of Greenwich, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6683-9114","authenticated-orcid":false,"given":"Zoe","family":"Drymoussi","sequence":"additional","affiliation":[{"name":"BARC (Barts Research Centre for Women\u2019s Health), Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Lanz","sequence":"additional","affiliation":[{"name":"BARC (Barts Research Centre for Women\u2019s Health), Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiamaka Esther","family":"Amaefule","sequence":"additional","affiliation":[{"name":"BARC (Barts Research Centre for Women\u2019s Health), Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jose","family":"Gonzalez Carreras","sequence":"additional","affiliation":[{"name":"BARC (Barts Research Centre for Women\u2019s Health), Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Carmen","family":"Pardo Llorente","sequence":"additional","affiliation":[{"name":"Department of Statistics and Operational Research, Complutense University of Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dodds","sequence":"additional","affiliation":[{"name":"BARC (Barts Research Centre for Women\u2019s Health), Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pizzo","sequence":"additional","affiliation":[{"name":"Applied Health Research, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Thomas","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Unit, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Heighway","sequence":"additional","affiliation":[{"name":"BARC (Barts Research Centre for Women\u2019s Health), Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Harden","sequence":"additional","affiliation":[{"name":"City University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Sanghi","sequence":"additional","affiliation":[{"name":"Obstetrics & Gynaecology, The Royal London Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Hitman","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-588X","authenticated-orcid":false,"given":"Javier","family":"Zamora","sequence":"additional","affiliation":[{"name":"Hospital Ramon y Cajal, Madrid, Spain"},{"name":"University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0439-8952","authenticated-orcid":false,"given":"Teresa","family":"P\u00e9rez","sequence":"additional","affiliation":[{"name":"Department of Statistics and Data Science, Complutense University of Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S B","family":"Huda","sequence":"additional","affiliation":[{"name":"Department of Diabetes & Metabolism, The Royal London Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakila","family":"Thangaratinam","sequence":"additional","affiliation":[{"name":"University of Birmingham, Birmingham, UK"},{"name":"Birmingham Women\u2019s and Children\u2019s NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"2025121219411853000_13.11.e073813.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023"},{"key":"2025121219411853000_13.11.e073813.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.11.002"},{"key":"2025121219411853000_13.11.e073813.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60731-5"},{"key":"2025121219411853000_13.11.e073813.4","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.wombi.2014.09.002","article-title":"A review of interventions to prevent type 2 diabetes after gestational diabetes","volume":"27","author":"Peacock","year":"2014","journal-title":"Women Birth"},{"key":"2025121219411853000_13.11.e073813.5","first-page":"658","article-title":"Metformin: Current knowledge","volume":"19","author":"Nasri","year":"2014","journal-title":"J Res Med Sci"},{"key":"2025121219411853000_13.11.e073813.6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajog.2017.06.003","article-title":"Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of Preeclampsia and cancer, and the promotion of longevity","volume":"217","author":"Romero","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2025121219411853000_13.11.e073813.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512"},{"key":"2025121219411853000_13.11.e073813.8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0772"},{"key":"2025121219411853000_13.11.e073813.9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2020.100139","article-title":"A randomized trial of Dapagliflozin and metformin, alone and combined, in overweight women after gestational diabetes mellitus","volume":"2","author":"Elkind-Hirsch","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"2025121219411853000_13.11.e073813.10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107548","article-title":"Postpartum treatment with Liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight\/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study","volume":"34","author":"Elkind-Hirsch","year":"2020","journal-title":"J Diabetes Complications"},{"key":"2025121219411853000_13.11.e073813.11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S2213-8587(15)00234-X","article-title":"Metformin and pregnancy outcomes in obese women","volume":"3","author":"Refuerzo","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025121219411853000_13.11.e073813.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036198","article-title":"Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: A protocol for a randomised, placebo-controlled, double-blind feasibility trialOptimising health outcomes with metformin to prevent diAbetes after pregnancy (Omaha)","volume":"10","author":"Amaefule","year":"2020","journal-title":"BMJ Open"},{"key":"2025121219411853000_13.11.e073813.13","unstructured":"Excellence, C . Guide to the methods of technology appraisal 2013. 2013."},{"key":"2025121219411853000_13.11.e073813.14","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2025121219411853000_13.11.e073813.15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/1471-0528.14419","article-title":"Involving pregnant women, mothers and members of the public to improve the quality of women\u2019s health research","volume":"124","author":"Moss","year":"2017","journal-title":"BJOG"},{"key":"2025121219411853000_13.11.e073813.16","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0532"},{"key":"2025121219411853000_13.11.e073813.17","doi-asserted-by":"crossref","DOI":"10.5888\/pcd16.190144","article-title":"Racial\/ethnic differences in diabetes screening and hyperglycemia among US women after gestational diabetes","volume":"16","author":"Bower","year":"2019","journal-title":"Prev Chronic Dis"},{"key":"2025121219411853000_13.11.e073813.18","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2004.029124"},{"key":"2025121219411853000_13.11.e073813.19","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2393-14-41","article-title":"From screening to postpartum follow-up - the determinants and barriers for gestational diabetes mellitus (GDM) services, a systematic review","volume":"14","author":"Nielsen","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025121219411853000_13.11.e073813.20","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.230","article-title":"Diabetes prevention interventions for women after gestational diabetes mellitus: an overview of reviews","volume":"4","author":"Hedeager Momsen","year":"2021","journal-title":"Endocrinol Diabetes Metab"},{"key":"2025121219411853000_13.11.e073813.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050099","article-title":"Acceptability and adherence to a Mediterranean diet in the postnatal period to prevent type 2 diabetes in women with gestational diabetes in the UK: a protocol for a single-arm feasibility study (MERIT)","volume":"11","author":"Bolou","year":"2021","journal-title":"BMJ Open"},{"key":"2025121219411853000_13.11.e073813.22","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.4.623"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-073813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:41:29Z","timestamp":1765597289000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-073813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,28]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bmjopen-2023-073813"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-073813","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}